Oxidized low-density lipoprotein stimulates monocyte adhesion to glomerular endothelial cells

Kidney International

Volumn 55, Issue 6, 1999, Pages 2192-2202

  Kamanna, Vaijinath S ^a,b   Rama, Pai ^a,b   Hunjoo, Ha ^a,c   Kirschenbaum, Michael A ^a   Roh, Daeyoung D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Cell signaling; Glomerulosclerosis; Intracellular signaling; Lipid metabolism; Lipoprotein

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL INTERACTION; ENDOTHELIUM CELL; GLOMERULUS EPITHELIUM; LEUKOCYTE ADHERENCE; LIPID PEROXIDATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0033031770     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00470.x     Document Type: Article

References (49)

1. 1. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 39(Suppl 31):S41-S48, 1991
2. 2. Kamanna VS, Roh DD, Kirschenbaum MA: Atherogenic lipoproteins: Mediators of glomerular injury. Am J Nephrol 13:1-5, 1993
3. 3. Massy ZA, Ma JZ, Louis TA, Kasiske BL: Lipid lowering therapy in patients with renal disease. Kidney Int 48:188-198, 1995
4. 4. Kamanna VS, Kirschenbaum MA: Association between very low density lipoproteins and glomerular injury in obese Zucker rats. Am J Nephrol 13:53-58, 1993
5. 5. Pai R, Kirschenbaum MA, Kamanna VS: Low density lipoprotein stimulates the expression of macrophage colony stimulating factor in glomerular mesangial cells. Kidney Int 48:1254-1262, 1995
6. 6. Kamanna VS, Pai R, Ron DD, Kirschenbaum MA: Oxidative modification of low density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration and proliferation. Lab Invest 74:1067-1079, 1996
7. 7. Ha H, Ron DD, Kirschenbaum MA, Kamanna VS: Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor: Role of protein tyrosine kinase and cyclic AMP-dependent protein kinase A. J Lab Clin Med 131:456-465, 1998
8. 8. Rovin BH, Tan LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43:218-225, 1993
9. 9. Kamanna VS, Bassa BV, Kirschenbaum MA: Atherogenic lipoproteins and human disease: Extending concepts beyond the heart to the kidney. Curr Opin Nephrol Hypertens 6:205-211, 1997
10. 10. Kirschenbaum MA, Pai R, Ron DD, Kamanna VS: Role of atherogenic lipoproteins in cytokine-mediated renovascular injury. Miner Electrolyte Metab 22:47-50, 1996
11. 11. Magil AB, Cohen AH: Monocytes and focal glomerulosclerosis. Lab Invest 61:404-409, 1989
12. 12. Schreiner GF: The role of macrophage in glomerular injury. Semin Nephrol 11:268-275, 1991
13. 13. Rice GE, Munro JM, Corless C, Bevilacqua MP: Vascular and nonvascular expression of INCAM-110: A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol 138:385-393, 1991
14. 14. Carlos T, Kovach N, Schwartz B, Rosa M, Newman B, Wayner E, Benjamin C, Osborn L, Lobb R, Harlan J: Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: Endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 77:2266-2271, 1991
15. 15. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA: Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene family. Cell 52:925-933, 1988
16. 16. Boyd AW, Wawryk SO, Burns GF, Fecondo JV: Intercellular adhesion molecule-1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms, Proc Natl Acad Sci USA 85:3095-3099, 1988
17. 17. Marlin SD, Springer TA: Purified intercellular adhesion molecule-1 (ICAM) is a ligand for lymphocyte function associated antigen-1 (LFA-1). Cell 51:813-819, 1987
18. 18. Dustin ML, Springer TA: Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 107:321-331, 1988
19. 19. Block LH, Knoor M, Vogt E, Locher R, Vetter W, Groscurth P, Qiao B, Pometta D, James R, Regenass M, Pletscher A: Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci USA 85:885-889, 1988
20. 20. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA: Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 92:471-479, 1993
21. 21. Flavahan NA: Atherosclerosis or lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying the reduction in EDRF/nitric oxide activity. Circulation 85:1927-1938, 1992
22. 22. Shimokawa H, Flavahan NA, Vanhoutte PM: Loss of endothelial pertussis toxin-sensitive G-protein function in atherosclerotic porcine coronary arteries. Circulation 83:652-660, 1991
23. i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest 95:1457-1463, 1995
24. 24. Flavahan NA: Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells. Am J Physiol 264:H722-H727, 1993
25. 25. Bassa BV, Roh DD, Kirschenbaum MA, Kamanna VS: Atherogenic lipoproteins stimulate mesangial cell mitogen-activated protein kinase. J Am Soc Nephrol 9:488-496, 1998
26. 26. Kamanna VS, Bassa BV, Vaziri ND, Roh DD: Atherogenic lipoproteins and tyrosine kinase mitogenic signaling in mesangial cells. Kidney Int Suppl (in press)
27. 27. McGregor PE, Agrawal DK, Edwards JD: Attenuation of human leukocyte adherence to endothelial cell monolayers by tyrosine kinase inhibitors. Biochem Biophys Res Commun 198:359-365, 1994
28. 28. Pai R, Bassa B, Kirschenbaum MA, Kamanna VS: TNF-α stimulates monocyte adhesion to glomerular mesangial cells: The role of intercellular adhesion molecule-1 gene expression and protein kinases. J Immunol 156:2571-2579, 1996
29. 29. Walther BT, Ohman K, Roseman SA: A quantitative assay for intercellular adhesion. Proc Natl Acad Sci USA 70:1569-1573, 1973
30. 30. Uehara Y, Fukazawa H: Use and selectivity of herbimycin A as inhibitor of protein tyrosine kinases. Methods Enzymol 201:370-379, 1991
31. 31. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-chloroform extraction. Anal Biochem 162:156-160, 1989
32. 32. Liao F, Berliner JA, Meiirabian M, Navab M, Demer LL: Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 87:2253-2257, 1991
33. 33. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM: Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85:1260-1266, 1990
34. 34. Schwartz D, Andalibi A, Chaverri-Almada L, Berliner JA, Kirchgessner T, Fang Z, Tekamp-Olson P, Lusis AJ, Gallegos C, Fogelman AM, Territo MC: Role of GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J Clin Invest 94:1968-1973, 1994
35. 35. Kume N, Cybulsky MI, Gimbrone MA Jr: Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90:1138-1144, 1992
36. 36. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol, modification of low density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
37. 37. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87:5134-5138, 1990
38. 38. Keane WF, O'Donnell MP, Kasiske BL, Kim Y: Oxidative modification of low density lipoproteins by mesangial cells. J Am Soc Nephrol 4:187-194, 1993
39. 39. Magil AB, Frohlich JJ, Innis SM, Steinbrecher WP: Oxidized low density lipoproteins in experimental focal glomerulosclerosis. Kidney Int 43:1243-1250, 1993
40. 40. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, Foret M, Favier A, Cordonnier D: Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57:10-15, 1991
41. 41. Dasgupta A, Hussain S, Ahmad S: Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 60:56-59, 1992
42. 42. Lee HS, Kim YS: Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int 54:848-856, 1998
43. 43. Guevara J Jr, Walch ET, Epstein HF, Sparrow JT, Gotto AM, Valentinova NV: Evidence that apo B-100 of low density lipoprotein is a novel Src-related protein kinase. J Protein Chem 14:627-631, 1995
44. 44. Weber C, Negrescu E, Erl W, Pietsch A, Frankenberger M, Heitbrock HWL, Siess W, Weber PC: Inhibitors of protein tyrosine kinase supports TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol 155:445-451, 1995
45. 45. Satriano J, Schlondroff D: Activation and attenuation of transcription factor NF-KB in mouse glomerular mesangial cells in response to tumor necrosis factor-α, immunoglobulin G, and adenosine 3', 5'-cyclic monophosphate: Evidence for involvement of reactive oxygen species. J Clin Invest 94:1629-1636, 1994
46. 46. Zhu Y, Lin J, Liao H-L, Verna L, Stemerman MB: Activation of ICAM-1 promoter by lysophosphatidylcholine: Possible involvement of protein tyrosine kinases. Biochim Biophys Acta 1345:93-98, 1997
47. 47. Durieu-Trautmann O, Chavert N, Cazaubon S, Strosberg D, Couraud PO: Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem 269: 12536-12540, 1994
48. 48. Chirathaworn C, Tibbetts SA, Chan MA, Benedict SH: Cross-linking of ICAM-1 on T-cells induces transient tyrosine phosphorylation and inactivation of cdc2 kinase. J Immunol 155:5479-5482, 1995
49. 2-integrin LFA-1 signaling through phospholipase C-γ1 activation. Proc Natl Acad Sci USA 90:7099-7103, 1993